cancer

As cannabis legalization continues to expand across the U.S., its use among cancer patients has also increased significantly, particularly for managing symptoms like nausea, pain, anxiety and insomnia. A recent blog entry from Carmen Phillips at the National Cancer Institute (NCI), a part of...

Silexion Therapeutics Corp. (NASDAQ:SLXN) stock is up more than 21.72% in pre-market trading Tuesday after the company revealed new findings from a Phase 2 trial for its first-generation product, LODER. Overall, the updated analysis reveals a 56% objective response rate (ORR) in patients treated...

Ideaya Biosciences Inc. (NASDAQ:IDYA), a precision medicine oncology company, released interim Phase 2 clinical trial data. The data centers on darovasertib in neoadjuvant (therapy before surgery) for uveal melanoma (UM) and an FDA Type C meeting on registrational trial design for regulatory...

ARK Invest’s multiomics analyst, Nemo M Despot, and the firm’s leader, Cathie Wood, have hinted at a revolutionary approach to healthcare, leveraging multiomics, artificial intelligence, and big data. What Happened: On Thursday, Despot, a multiomics analyst at ARK Invest, took...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares closed slightly higher Wednesday after the company provided an update from its ongoing Phase 1/1b clinical trial of BP1001-A in solid tumor patients and reported continued patient progress from its ongoing Phase 2 triple combination study of...

Turnstone Biologics Corp. (NASDAQ:TSBX) stock is trading lower after the company released initial data from its Phase 1 STARLING trial of TIDAL-01 in metastatic microsatellite-stable colorectal cancer (MSS mCRC) on Thursday. TIDAL-01 is a tumor-infiltrating lymphocyte therapy. In cancer therapy,...

Editor’s Note: This story has been updated with more details. The tech industry is mourning the loss of Susan Wojcicki, the former CEO of YouTube, who has succumbed to cancer. Her death has sparked a wave of tributes, including a heartfelt message from Sundar Pichai, the CEO of Google-...

In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to pay up to $250 million. What Happened: The settlement, disclosed in a Delaware court filing last week, is intended to significantly reduce Pfizer’s potential liability,...

ImmunityBio Inc (NASDAQ:IBRX) shares are trading down after an early morning high on Friday after the company announced an exclusive global arrangement with the Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses produced, to supply ImmunityBio with ...

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic. But, in a post-pandemic world, Pfizer and Moderna shares lost about 30% of their respective value over the...

Following the unexpected cancer diagnosis of Kate Middleton (aka Catherine, Princess of Wales), several prominent figures have come forward to express their support. What Happened: First Lady Jill Biden, Ivanka Trump, former first daughter, First Lady of Florida Casey DeSantis and Jeff Bezos...

When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track record at treating. At the end of last year, Merck (NYSE: MRK) provided a non-...

Enveric Biosciences Inc. (NASDAQ:ENVB) said on Friday it has agreed to sell one of its cancer-related patent portfolios. The Cambridge, Massachusetts-based company didn't disclose the amount. The divested portfolio includes patents issued in the U.S., Australia, Canada, China, Europe and Japan,...

In September, Biden unveiled a $240 million investment to combat cancer, augmenting the administration’s “Cancer Moonshot”, an initiative with an array of new health resources.  The funding, allocated through the recently established Advanced Research Projects Agency for...

This article was originally published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission. Nearly a quarter of Canadian cancer survivors acknowledge consuming cannabis as a sleep aid, according to data published in the Journal of Cancer...